Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 22% ± 2% | |
glutamatergic neuron | 5 studies | 30% ± 15% | |
macrophage | 5 studies | 19% ± 3% | |
epithelial cell | 4 studies | 28% ± 7% | |
astrocyte | 4 studies | 23% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 5% | |
oligodendrocyte | 4 studies | 21% ± 4% | |
neuron | 3 studies | 22% ± 6% | |
myeloid cell | 3 studies | 16% ± 1% | |
fibroblast | 3 studies | 18% ± 3% | |
abnormal cell | 3 studies | 23% ± 2% | |
GABAergic neuron | 3 studies | 34% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 28% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6401.46 | 459 / 459 | 100% | 78.14 | 1118 / 1118 |
esophagus | 100% | 5781.45 | 1445 / 1445 | 100% | 49.81 | 183 / 183 |
ovary | 100% | 7109.49 | 180 / 180 | 100% | 61.47 | 430 / 430 |
prostate | 100% | 7550.30 | 245 / 245 | 100% | 63.65 | 502 / 502 |
skin | 100% | 6046.94 | 1809 / 1809 | 100% | 83.77 | 472 / 472 |
stomach | 100% | 4966.06 | 359 / 359 | 100% | 40.74 | 286 / 286 |
lung | 100% | 6141.29 | 578 / 578 | 100% | 57.45 | 1153 / 1155 |
brain | 100% | 4671.69 | 2636 / 2642 | 100% | 82.04 | 705 / 705 |
pancreas | 100% | 3162.31 | 327 / 328 | 100% | 53.05 | 178 / 178 |
thymus | 100% | 9015.48 | 653 / 653 | 100% | 65.86 | 603 / 605 |
intestine | 100% | 6151.16 | 966 / 966 | 100% | 40.60 | 525 / 527 |
uterus | 100% | 8716.82 | 170 / 170 | 100% | 61.41 | 457 / 459 |
bladder | 100% | 6347.43 | 21 / 21 | 99% | 56.16 | 501 / 504 |
kidney | 100% | 5409.83 | 89 / 89 | 99% | 43.43 | 893 / 901 |
liver | 100% | 2512.87 | 226 / 226 | 98% | 35.61 | 396 / 406 |
adrenal gland | 100% | 5523.79 | 258 / 258 | 96% | 54.54 | 221 / 230 |
adipose | 100% | 5890.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 85.48 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.78 | 29 / 29 |
muscle | 100% | 5075.82 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7108.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 52.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 44.68 | 1 / 1 |
blood vessel | 100% | 5595.00 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3628.44 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 4176.37 | 912 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0007165 | Biological process | signal transduction |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0048839 | Biological process | inner ear development |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005768 | Cellular component | endosome |
GO_0030867 | Cellular component | rough endoplasmic reticulum membrane |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004430 | Molecular function | 1-phosphatidylinositol 4-kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PI4KB |
Protein name | Phosphatidylinositol 4-kinase beta (EC 2.7.1.67) Phosphatidylinositol 4-kinase beta Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92) (PI4KIII) |
Synonyms | PIK4CB |
Description | FUNCTION: Phosphorylates phosphatidylinositol (PI) in the first committed step in the production of the second messenger inositol-1,4,5,-trisphosphate (PIP). May regulate Golgi disintegration/reorganization during mitosis, possibly via its phosphorylation. Involved in Golgi-to-plasma membrane trafficking (By similarity) . May play an important role in the inner ear development. .; FUNCTION: (Microbial infection) Plays an essential role in Aichi virus RNA replication . Recruited by ACBD3 at the viral replication sites . .; FUNCTION: (Microbial infection) Required for cellular spike-mediated entry of human coronavirus SARS-CoV. . |
Accessions | ENST00000489223.2 A0A0A0MSL0 Q9UBF8 ENST00000455060.5 ENST00000446339.1 ENST00000438243.2 H0Y4F8 ENST00000368873.6 [Q9UBF8-1] H0YCW3 E9PL47 ENST00000430800.5 ENST00000368872.5 [Q9UBF8-2] A6PVV8 ENST00000368874.8 [Q9UBF8-2] A0A0B4J1S8 ENST00000368875.6 ENST00000529142.5 [Q9UBF8-3] ENST00000489889.2 F8W860 |